发现作为潜在抗糖尿病药物的肼基环噻唑类化合物:合成、生物学评价和分子对接研究。

IF 3.5 4区 医学 Q2 CHEMISTRY, MEDICINAL
Betül Kaya, Hakan Tahtacı, Bilge Çiftçi, Hatice Esra Duran, Adem Necip, Mesut Işık, Şükrü Beydemir
{"title":"发现作为潜在抗糖尿病药物的肼基环噻唑类化合物:合成、生物学评价和分子对接研究。","authors":"Betül Kaya,&nbsp;Hakan Tahtacı,&nbsp;Bilge Çiftçi,&nbsp;Hatice Esra Duran,&nbsp;Adem Necip,&nbsp;Mesut Işık,&nbsp;Şükrü Beydemir","doi":"10.1002/ddr.70060","DOIUrl":null,"url":null,"abstract":"<p>In this study, hydrazine clubbed thiazole derivatives (<b>3a</b>–<b>3j</b>) were obtained by Hantzsch thiazole synthesis and characterized by MS, <sup>1</sup>H NMR, and <sup>13</sup>C NMR. The inhibitory potentials of the derivatives against diabetes-related enzymes such as aldose reductase (AR), α-glycosidase (α-GLY), and α-amylase (α-AMY) were experimentally determined, and the results were supported by molecular docking. The results showed that the derivatives (<b>3a</b>–<b>3j</b>) displayed varied degree of potential inhibitory activity, with <i>K</i><sub>I</sub> values covering the following ranges: 5.47 ± 0.53 to 23.89 ± 1.46 nM for AR and 1.76 ± 0.01 to 24.81 ± 0.15 μM for α-GLY, and with IC<sub>50</sub> values 4.94–28.17 μM for α-AMY, as compared to standard epalrestat and acarbose (<i>K</i><sub>I</sub>: 34.53 ± 2.52 nM for AR and 23.53 ± 2.72 μM for α-GLY, respectively). The selective activity of these derivatives on antidiabetic enzymes may be important for the treatment of diabetes and may lead to the development of alternative new compounds for this purpose.</p>","PeriodicalId":11291,"journal":{"name":"Drug Development Research","volume":"86 1","pages":""},"PeriodicalIF":3.5000,"publicationDate":"2025-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ddr.70060","citationCount":"0","resultStr":"{\"title\":\"Discovery of Hydrazine Clubbed Thiazoles as Potential Antidiabetic Agents: Synthesis, Biological Evaluation, and Molecular Docking Studies\",\"authors\":\"Betül Kaya,&nbsp;Hakan Tahtacı,&nbsp;Bilge Çiftçi,&nbsp;Hatice Esra Duran,&nbsp;Adem Necip,&nbsp;Mesut Işık,&nbsp;Şükrü Beydemir\",\"doi\":\"10.1002/ddr.70060\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>In this study, hydrazine clubbed thiazole derivatives (<b>3a</b>–<b>3j</b>) were obtained by Hantzsch thiazole synthesis and characterized by MS, <sup>1</sup>H NMR, and <sup>13</sup>C NMR. The inhibitory potentials of the derivatives against diabetes-related enzymes such as aldose reductase (AR), α-glycosidase (α-GLY), and α-amylase (α-AMY) were experimentally determined, and the results were supported by molecular docking. The results showed that the derivatives (<b>3a</b>–<b>3j</b>) displayed varied degree of potential inhibitory activity, with <i>K</i><sub>I</sub> values covering the following ranges: 5.47 ± 0.53 to 23.89 ± 1.46 nM for AR and 1.76 ± 0.01 to 24.81 ± 0.15 μM for α-GLY, and with IC<sub>50</sub> values 4.94–28.17 μM for α-AMY, as compared to standard epalrestat and acarbose (<i>K</i><sub>I</sub>: 34.53 ± 2.52 nM for AR and 23.53 ± 2.72 μM for α-GLY, respectively). The selective activity of these derivatives on antidiabetic enzymes may be important for the treatment of diabetes and may lead to the development of alternative new compounds for this purpose.</p>\",\"PeriodicalId\":11291,\"journal\":{\"name\":\"Drug Development Research\",\"volume\":\"86 1\",\"pages\":\"\"},\"PeriodicalIF\":3.5000,\"publicationDate\":\"2025-02-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ddr.70060\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Drug Development Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/ddr.70060\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CHEMISTRY, MEDICINAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Development Research","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/ddr.70060","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

摘要

本研究通过Hantzsch噻唑合成得到了肼棒状噻唑衍生物(3a-3j),并用MS、1H NMR和13C NMR对其进行了表征。实验测定了该衍生物对醛糖还原酶(AR)、α-糖苷酶(α-GLY)、α-淀粉酶(α-AMY)等糖尿病相关酶的抑制电位,并得到了分子对接的支持。结果表明,3 -3j衍生物具有不同程度的潜在抑制活性,其KI值分别为AR(5.47±0.53 ~ 23.89±1.46 nM)和α-GLY(1.76±0.01 ~ 24.81±0.15 μM), α-AMY的IC50值为4.94 ~ 28.17 μM,与依帕他他和阿卡波糖(AR和α-GLY的KI值分别为34.53±2.52 nM和23.53±2.72 μM)相比。这些衍生物对抗糖尿病酶的选择性活性可能对糖尿病的治疗很重要,并可能导致开发用于此目的的替代新化合物。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Discovery of Hydrazine Clubbed Thiazoles as Potential Antidiabetic Agents: Synthesis, Biological Evaluation, and Molecular Docking Studies

Discovery of Hydrazine Clubbed Thiazoles as Potential Antidiabetic Agents: Synthesis, Biological Evaluation, and Molecular Docking Studies

In this study, hydrazine clubbed thiazole derivatives (3a3j) were obtained by Hantzsch thiazole synthesis and characterized by MS, 1H NMR, and 13C NMR. The inhibitory potentials of the derivatives against diabetes-related enzymes such as aldose reductase (AR), α-glycosidase (α-GLY), and α-amylase (α-AMY) were experimentally determined, and the results were supported by molecular docking. The results showed that the derivatives (3a3j) displayed varied degree of potential inhibitory activity, with KI values covering the following ranges: 5.47 ± 0.53 to 23.89 ± 1.46 nM for AR and 1.76 ± 0.01 to 24.81 ± 0.15 μM for α-GLY, and with IC50 values 4.94–28.17 μM for α-AMY, as compared to standard epalrestat and acarbose (KI: 34.53 ± 2.52 nM for AR and 23.53 ± 2.72 μM for α-GLY, respectively). The selective activity of these derivatives on antidiabetic enzymes may be important for the treatment of diabetes and may lead to the development of alternative new compounds for this purpose.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
6.40
自引率
2.60%
发文量
104
审稿时长
6-12 weeks
期刊介绍: Drug Development Research focuses on research topics related to the discovery and development of new therapeutic entities. The journal publishes original research articles on medicinal chemistry, pharmacology, biotechnology and biopharmaceuticals, toxicology, and drug delivery, formulation, and pharmacokinetics. The journal welcomes manuscripts on new compounds and technologies in all areas focused on human therapeutics, as well as global management, health care policy, and regulatory issues involving the drug discovery and development process. In addition to full-length articles, Drug Development Research publishes Brief Reports on important and timely new research findings, as well as in-depth review articles. The journal also features periodic special thematic issues devoted to specific compound classes, new technologies, and broad aspects of drug discovery and development.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信